Department of Pediatrics, Children's Hospital of Wisconsin of the Children's Research Institute/Medical College of Wisconsin, Hematology/Oncology/Bone Marrow Transplantation, Milwaukee, Wisconsin 53226, USA.
Pediatr Blood Cancer. 2013 Aug;60(8):1338-44. doi: 10.1002/pbc.24491. Epub 2013 Feb 25.
Sickle cell disease (SCD) is an inherited chronic disease that is characterized by complications such as recurrent painful vaso-occlusive events that require frequent hospitalizations and contribute to early mortality. The objective of the study was to report on the initial measurement properties of the new PedsQL™ SCD Module for pediatric patient self-report ages 5-18 years and parent proxy-report for ages 2-18 years.
The 43-item PedsQL™ SCD Module was completed in a multisite study by 243 pediatric patients with SCD and 313 parents. Participants also completed the PedsQL™ 4.0 Generic Core Scales and PedsQL™ Multidimensional Fatigue Scale.
The PedsQL™ SCD Module Scales evidenced excellent feasibility, excellent reliability for the Total Scale Scores (patient self-report α = 0.95; parent proxy-report α = 0.97), and good reliability for the nine individual scales (patient self-report α = 0.69-0.90; parent proxy-report α = 0.83-0.97). Intercorrelations with the PedsQL™ Generic Core Scales and PedsQL™ Multidimensional Fatigue Scales were medium (0.30) to large (0.50) range, supporting construct validity. PedsQL™ SCD Module Scale Scores were generally worse for patients with severe versus mild disease. Confirmatory factor analysis demonstrated an acceptable to excellent model fit.
The PedsQL™ SCD Module demonstrated acceptable measurement properties. The PedsQL™ SCD Module may be utilized in the evaluation of SCD-specific health-related quality of life in clinical research and practice. In conjunction with the PedsQL™ Generic Core Scales and the PedsQL™ Multidimensional Fatigue Scale, the PedsQL™ SCD Module will facilitate the understanding of the health and well-being of children with SCD.
镰状细胞病(SCD)是一种遗传性慢性疾病,其特征是经常发生反复发作的疼痛性血管阻塞事件,需要频繁住院治疗,并导致早期死亡。本研究的目的是报告新的 PedsQL™SCD 模块在 5-18 岁儿科患者自我报告和 2-18 岁父母代理报告中的初始测量特性。
在一项多中心研究中,243 名 SCD 儿科患者和 313 名父母完成了 43 项 PedsQL™SCD 模块。参与者还完成了 PedsQL™4.0 通用核心量表和 PedsQL™多维疲劳量表。
PedsQL™SCD 模块量表具有极好的可行性,总量表得分具有极好的可靠性(患者自我报告α=0.95;父母代理报告α=0.97),以及九个单独量表的良好可靠性(患者自我报告α=0.69-0.90;父母代理报告α=0.83-0.97)。与 PedsQL™通用核心量表和 PedsQL™多维疲劳量表的相关性为中等(0.30)至较大(0.50),支持结构效度。SCD 严重程度患者的 PedsQL™SCD 模块量表评分通常较差。验证性因子分析表明模型拟合度为可接受至优秀。
PedsQL™SCD 模块具有可接受的测量特性。在临床研究和实践中,PedsQL™SCD 模块可用于评估 SCD 特异性健康相关生活质量。与 PedsQL™通用核心量表和 PedsQL™多维疲劳量表一起,PedsQL™SCD 模块将有助于了解 SCD 儿童的健康和幸福感。